Impact BioMedical Inc. announced the issuance of U.S. Patent No. 12,357,584 B2, titled 'Composition and Method of Controlling Infectious Diseases with Functional Fragrances,' within its 3F™ technology platform. This patent, set to expire on December 7, 2038, relates to unique compositions and methods for controlling infectious diseases.
The patent covers compositions and formulations of plant-derived constituents and fragrances with potential application as antibacterial or antiviral agents. These formulations have demonstrated unique antimicrobial and antiviral properties, with potential effectiveness against pathogens including E. coli, MRSA, influenza, rhinovirus, and M. tuberculosis.
The worldwide infectious disease market is projected to grow from $21.7 billion in 2024 to $34 billion in 2032, representing a Compound Annual Growth Rate (CAGR) of 5.77%. IBO CEO Frank Heuszel stated the company is continuing discussions with potential partners to move 3F™ towards the market in the US and other countries worldwide.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.